HCBBS Forum (English)
Submit Chemical Projects / Find Solutions
Amplify Your Requirements on a Broader Chemical Platform *Engineering · Technology · Equipment · Solutions*
Submit Request

12 new locally transmitted confirmed cases and 1 locally transmitted asymptomatic case reported in Henan Province

2021-11-12View Original

Thread Content

News from Zhengzhou, China National Radio Network, November 12 (Reporter: Xia Sha) On November 12, reporters learned from the Health Commission of Henan Province that between 0:00 and 24:00 on November 11, 12 new locally confirmed cases were recorded across the province (6 in Zhengzhou City, including 5 cases where asymptomatic patients were reclassified as confirmed cases); 6 cases in Zhoukou City, all of whom were previously asymptomatic infected persons who later became confirmed cases); 1 new locally acquired asymptomatic infected person (in Zhoukou City), 3 new imported asymptomatic infected persons, and no new suspected cases ; 1 imported confirmed case was discharged after recovery, and 5 imported asymptomatic carriers were released from medical observation. From July 31, 2021, to 24:00 on November 11, a total of 234 locally confirmed cases were reported across the province, with 164 of those patients having been discharged from hospitals. Currently, there are 70 confirmed cases under isolation treatment at designated hospitals. From January 21, 2020, to 24:00 on November 11, 2021, a total of 1,628 confirmed cases were reported across the province (1,507 locally transmitted and 121 imported), with 82 patients currently hospitalized (70 locally transmitted and 12 imported). There are 12 asymptomatic cases still under medical observation (1 locally transmitted and 11 imported). A total of 48,133 close contacts have been identified, with 2,672 of them still under observation.

Submit a Project

**Looking for Chemical Technology, Equipment & Solutions?** No Registration Required Broader Platform Exposure | Global Chemical Service Provider Connections

Submit Request — Free Consultation

Disclaimer

This is an automated machine translation of the original thread. Some technical terms may have inaccuracies; the original text shall prevail. Click "View Original" at the top right to access the source page, which supports IP-based automatic real-time language translation. Please watch out for contact details and sales inducements to prevent fraud. All content and translations are for reference only, representing solely the poster's personal views. For enquiries, email service@hcbbs.com.